Suzhou Highfine Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Cash & Equivalents	408.66	361.08	1,740	99.32	78.05
Trading Asset Securities	902.02	1,346	30.76	60	45
Cash & Short-Term Investments	1,311	1,707	1,770	159.32	123.05
Cash Growth	-23.23%	-3.56%	1011.12%	29.48%	20.56%
Accounts Receivable	189.26	98.34	63.56	53.42	69.11
Other Receivables	1.19	11.78	0.49	1.71	3.47
Receivables	190.45	110.12	64.05	55.12	72.58
Inventory	161.18	116.7	115	113.45	78.89
Other Current Assets	27.68	10.13	14.69	24.77	15.72
Total Current Assets	1,690	1,944	1,964	352.67	290.24
Property, Plant & Equipment	631.42	320.39	286.46	206.24	142.63
Long-Term Investments	122.6	-	-	-	-
Goodwill	57.85	-	-	-	-
Other Intangible Assets	105.43	66.33	24.02	24.59	25.17
Long-Term Deferred Tax Assets	11.99	4.39	3.66	3.95	2.37
Long-Term Deferred Charges	0.35	0.1	0.08	0.26	0.29
Other Long-Term Assets	34.76	14.14	8.71	12.34	4.4
Total Assets	2,654	2,350	2,287	600.05	465.09
Accounts Payable	152.31	27.21	24.9	36.46	25.59
Accrued Expenses	19.62	17.95	16.68	23.26	15.24
Short-Term Debt	10.01	-	-	-	-
Current Portion of Long-Term Debt	1.41	-	-	-	-
Current Portion of Leases	-	1.68	0.83	1.04	1.03
Current Income Taxes Payable	8.36	4.59	3.28	13.94	5.84
Current Unearned Revenue	0.78	1.38	0.61	0.6	2.34
Other Current Liabilities	46.38	18.35	19.53	34.04	34.8
Total Current Liabilities	238.87	71.16	65.84	109.33	84.84
Long-Term Debt	39.47	-	-	-	-
Long-Term Leases	0.44	1.6	0.72	0.39	1.17
Long-Term Unearned Revenue	9.22	7.65	8.45	7.94	6.52
Long-Term Deferred Tax Liabilities	7.24	0.94	0.07	0.12	-
Total Liabilities	295.24	81.35	75.08	117.77	92.53
Common Stock	108	108	108	81	81
Additional Paid-In Capital	1,690	1,686	1,683	54.79	54.79
Retained Earnings	583.39	511.55	417.69	345.72	236.6
Treasury Stock	-33.42	-42	-	-	-
Comprehensive Income & Other	4.95	4.44	2.99	0.77	0.18
Total Common Equity	2,353	2,268	2,212	482.28	372.57
Minority Interest	6.33	-	-	-	-
Shareholders' Equity	2,359	2,268	2,212	482.28	372.57
Total Liabilities & Equity	2,654	2,350	2,287	600.05	465.09
Total Debt	51.33	3.28	1.56	1.43	2.2
Net Cash (Debt)	1,259	1,704	1,769	157.9	120.85
Net Cash Growth	-26.10%	-3.66%	1020.18%	30.65%	19.58%
Net Cash Per Share	11.75	15.76	19.12	1.95	1.50
Filing Date Shares Outstanding	108.68	106.97	108	81	81
Total Common Shares Outstanding	108.68	106.97	108	81	81
Working Capital	1,451	1,873	1,898	243.34	205.4
Book Value Per Share	21.65	21.20	20.48	5.95	4.60
Tangible Book Value	2,190	2,202	2,188	457.68	347.4
Tangible Book Value Per Share	20.15	20.58	20.26	5.65	4.29
Buildings	-	183.65	171.81	74.32	64.69
Machinery	-	163.79	76.02	65.92	61.8
Construction In Progress	-	21.65	72.45	87.92	28.48

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.